HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John D Hainsworth Selected Research

Carboplatin (JM8)

12/2019A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
1/2018Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
1/2018Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).
1/2018Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2.
9/2017First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC).
10/2016Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
8/2015Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
8/2015Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute.
5/2015Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.
5/2015Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John D Hainsworth Research Topics

Disease

77Neoplasms (Cancer)
01/2022 - 02/2001
31Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
29Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 02/2001
21Carcinoma (Carcinomatosis)
03/2016 - 03/2002
17Disease Progression
01/2021 - 04/2003
16Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 11/2005
16Neutropenia
08/2015 - 07/2002
14Diarrhea
11/2015 - 05/2003
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 05/2002
11Fatigue
10/2012 - 01/2004
10Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2009 - 02/2002
8Prostatic Neoplasms (Prostate Cancer)
01/2017 - 03/2006
7Hypertension (High Blood Pressure)
01/2022 - 05/2005
7Adenocarcinoma
08/2015 - 04/2005
7Thrombocytopenia (Thrombopenia)
10/2012 - 03/2003
6Neoplasm Metastasis (Metastasis)
10/2018 - 06/2005
6Exanthema (Rash)
09/2017 - 12/2007
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2015 - 01/2003
5Anemia
11/2015 - 01/2010
5Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 05/2005
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2008 - 01/2003
4Pathologic Complete Response
04/2020 - 07/2002
4Stomatitis
03/2016 - 12/2011
4Infections
03/2016 - 10/2011
4Lung Neoplasms (Lung Cancer)
03/2016 - 05/2003
4Esophageal Neoplasms (Esophageal Cancer)
07/2012 - 02/2001
4Nausea
12/2011 - 11/2005
3Glioblastoma (Glioblastoma Multiforme)
09/2019 - 08/2010
3Hemorrhage
01/2018 - 05/2005
3Triple Negative Breast Neoplasms
08/2017 - 08/2015
3Melanoma (Melanoma, Malignant)
01/2016 - 09/2010
3Carcinoid Tumor (Carcinoid)
12/2015 - 12/2011
3Basal Cell Carcinoma (Rodent Ulcer)
06/2015 - 06/2012
3Ovarian Neoplasms (Ovarian Cancer)
05/2015 - 09/2006
3Lymphoma (Lymphomas)
04/2015 - 01/2003
3Hypersensitivity (Allergy)
10/2012 - 05/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 07/2002
3Head and Neck Neoplasms (Head and Neck Cancer)
09/2011 - 07/2002
3Vomiting
10/2010 - 11/2005
3Fever (Fevers)
10/2010 - 07/2002
3Brain Neoplasms (Brain Tumor)
03/2010 - 03/2003

Drug/Important Bio-Agent (IBA)

39Carboplatin (JM8)FDA LinkGeneric
12/2019 - 03/2002
31Paclitaxel (Taxol)FDA LinkGeneric
08/2017 - 02/2001
30Bevacizumab (Avastin)FDA Link
09/2019 - 05/2005
22GemcitabineFDA Link
10/2016 - 02/2001
20Docetaxel (Taxotere)FDA Link
01/2019 - 02/2001
16Rituximab (Mabthera)FDA Link
08/2015 - 02/2002
14EverolimusFDA Link
10/2021 - 05/2010
14taxaneIBA
04/2020 - 01/2002
12Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 11/2005
11Pharmaceutical PreparationsIBA
12/2011 - 02/2002
10Sunitinib (Sutent)FDA Link
10/2021 - 05/2010
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 06/2003
10Sorafenib (BAY 43-9006)FDA Link
11/2017 - 01/2010
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 05/2005
9ErbB Receptors (EGF Receptor)IBA
10/2018 - 11/2005
9Doxorubicin (Adriamycin)FDA LinkGeneric
08/2017 - 01/2002
9Irinotecan (Camptosar)FDA LinkGeneric
08/2012 - 05/2003
8Trastuzumab (Herceptin)FDA Link
01/2018 - 10/2008
8Prednisone (Sone)FDA LinkGeneric
01/2017 - 06/2003
8Etoposide (VP 16)FDA LinkGeneric
01/2010 - 05/2002
7Hormones (Hormone)IBA
01/2020 - 11/2003
7Pemetrexed (MTA)FDA Link
12/2019 - 06/2010
7Fluorouracil (Carac)FDA LinkGeneric
07/2012 - 01/2002
6AnthracyclinesIBA
04/2020 - 08/2006
6Vinorelbine (Navelbine)FDA LinkGeneric
08/2009 - 02/2001
5PlatinumIBA
01/2018 - 05/2002
5ixabepilone (BMS 247550)FDA Link
08/2017 - 10/2012
5Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2011 - 07/2008
5Topotecan (Hycamtin)FDA LinkGeneric
05/2011 - 05/2002
5Gefitinib (Iressa)FDA Link
01/2010 - 05/2003
4Taxoids (Taxanes)IBA
01/2019 - 08/2006
4HhAntag691IBA
01/2018 - 06/2012
4Vincristine (Oncovin)FDA LinkGeneric
08/2015 - 06/2003
4Capecitabine (Xeloda)FDA Link
05/2010 - 07/2008
4Monoclonal AntibodiesIBA
09/2005 - 01/2003
3AndrogensIBA
01/2022 - 05/2011
3pegfilgrastim (Neulasta)FDA Link
01/2018 - 06/2008
3Epidermal Growth Factor (EGF)IBA
01/2018 - 05/2010
3pazopanibFDA Link
01/2018 - 09/2013
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2016 - 08/2010
3Octreotide (Sandostatin)FDA LinkGeneric
12/2015 - 12/2011
3Abiraterone AcetateIBA
10/2015 - 05/2011
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2013 - 09/2008
3Cytotoxins (Cytolysins)IBA
10/2012 - 08/2006
3Temozolomide (Temodar)FDA LinkGeneric
04/2012 - 05/2003
3Angiogenesis InhibitorsIBA
08/2011 - 01/2010
3vinflunineIBA
11/2010 - 03/2010
3Epirubicin (Ellence)FDA LinkGeneric
10/2010 - 08/2006
3Imatinib Mesylate (Gleevec)FDA Link
11/2009 - 09/2007
2Androgen Receptors (Androgen Receptor)IBA
01/2022 - 09/2012

Therapy/Procedure

57Therapeutics
10/2021 - 02/2002
42Drug Therapy (Chemotherapy)
01/2018 - 02/2001
12Radiotherapy
01/2016 - 02/2001
11Neoadjuvant Therapy
04/2020 - 06/2008
10Combination Drug Therapy (Combination Chemotherapy)
01/2018 - 03/2002
6Castration
01/2017 - 03/2010
5Combined Modality Therapy
04/2012 - 07/2002
3Aftercare (After-Treatment)
01/2017 - 05/2010
3Induction Chemotherapy
09/2011 - 02/2001